Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · IEX Real-Time Price · USD
9.40
-0.10 (-1.05%)
At close: Mar 28, 2024, 4:00 PM
9.48
+0.08 (0.85%)
After-hours: Mar 28, 2024, 7:58 PM EDT
Mind Medicine (MindMed) Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for MNMD stock have an average target of 30.5, with a low estimate of 7.00 and a high estimate of 75. The average target predicts an increase of 224.47% from the current stock price of 9.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MNMD stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +697.87% | Mar 14, 2024 |
RBC Capital | RBC Capital | Buy Maintains $15 → $22 | Buy | Maintains | $15 → $22 | +134.04% | Mar 8, 2024 |
Roth MKM | Roth MKM | Strong Buy Maintains $25 → $36 | Strong Buy | Maintains | $25 → $36 | +282.98% | Mar 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +697.87% | Mar 1, 2024 |
RBC Capital | RBC Capital | Buy Maintains $14 → $15 | Buy | Maintains | $14 → $15 | +59.57% | Feb 29, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.99
from -2.44
EPS Next Year
-1.72
from -1.99
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 157.3M | 518.5M | 1.1B |
Avg | n/a | n/a | 43.3M | 139.5M | 397.7M |
Low | n/a | n/a | n/a | n/a | 60.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 1,096.3% | 698.5% |
Avg | - | - | - | 221.9% | 185.0% |
Low | - | - | - | - | -56.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.77 | -1.47 | -1.19 | 3.55 | 9.58 |
Avg | -1.99 | -1.72 | -1.53 | -0.24 | 2.23 |
Low | -2.25 | -1.91 | -1.97 | -2.53 | -1.78 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.